Abbott Laboratories P/E Ratio 2007–2025
Abbott Laboratories reported 33.07 of price-to-earnings ratio for fiscal 2025. That was 131.8% higher than fiscal 2024. Compared with fiscal 2020, the change was -15.8%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 33.07 | +131.8% |
| FY 2024 | 14.26 | -55.3% |
| FY 2023 | 31.89 | +22.7% |
| FY 2022 | 26.00 | -20.1% |
| FY 2021 | 32.54 | -17.2% |
| FY 2020 | 39.28 | +5.5% |
| FY 2019 | 37.23 | -21.2% |
| FY 2018 | 47.24 | -73.8% |
| FY 2017 | 180.30 | +429.3% |
| FY 2016 | 34.07 | +172.4% |
| FY 2015 | 12.51 | -48.0% |
| FY 2014 | 24.06 | +30.6% |
| FY 2013 | 18.43 | +36.6% |
| FY 2012 | 13.49 | -2.7% |
| FY 2011 | 13.86 | +19.8% |
| FY 2010 | 11.58 | +14.4% |
| FY 2009 | 10.12 | -11.6% |
| FY 2008 | 11.45 | -27.8% |
| FY 2007 | 15.86 | — |
Source: Abbott Laboratories SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ABT 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Abbott Laboratories reported 33.07 of price-to-earnings ratio for fiscal 2025. That was 131.8% higher than fiscal 2024. Compared with fiscal 2020, the change was -15.8%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Abbott Laboratories
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAbbott Laboratories — frequently asked questions
What is Abbott Laboratories's price-to-earnings ratio?
Abbott Laboratories (ABT) reported price-to-earnings ratio of 33.07 for fiscal year 2025, per its SEC filings.
How has Abbott Laboratories's price-to-earnings ratio changed over time?
Between fiscal 2007 and 2025, ABT's price-to-earnings ratio grew at roughly 4.2% per year (compound annual rate), from 15.86 to 33.07.
Where does this data come from?
Figures are computed from Abbott Laboratories's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More ABT financial history
Full ABT fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →